We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Find out about the long-term effects some people can have after having COVID-19.
Guidance for people with symptoms of a respiratory infection including COVID-19, or a positive test result for COVID-19.
The epidemiology, symptoms, diagnosis and management of monkeypox virus infections.
Lassa virus causes Lassa fever, an acute viral haemorrhagic fever (VHF).
Safety leaflet on topical corticosteroids and withdrawal reactions to help patients and their carers to use these medicines safely.
Advice to give pregnant women on infections that can be transmitted via contact with animals that are or have recently given birth.
Information for health professionals on the characteristics, diagnosis and treatment of Pontiac fever.
These reports explain our assessment of the scientific evidence used to lead to regulatory decisions on the safety of medicines or medicines classes.
The characteristics, diagnosis, management, surveillance and epidemiology of Clostridioides difficile (C. difficile).
You must tell DVLA if you have obstructive sleep apnoea syndrome (OSAS) or any sleep condition or apnoea which causes excessive sleepiness.
Data on the real-world efficacy of the COVID-19 vaccines.
Specialist reference laboratory services for mycobacteriology available in the UK.
This indicator is a measure of the extent to which adults with a serious mental illness (SMI) die younger than adults without a serious mental illness (nSMI).
Results for the Vivaldi study for antibody and cellular immune responses to coronavirus (COVID-19) in approximately 340 care homes.
Information from the National Health Service on conditions, treatments, local services and healthy living
Pandemic flu planning information for England and the devolved administrations, including guidance for organisations and businesses.
Advice for medical professionals to follow when assessing drivers with miscellaneous conditions.
Information relating to rare side effects after vaccination.
Advice for medical professionals to follow when assessing drivers with visual disorders.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).